Table 1.
Baseline characteristics of T2DM patients with and without sarcopenia.
| Parameters | Non-sarcopenic (n = 67, 74.4%) | Sarcopenic n = 23, 25.6%) | P |
| Age (years) | 55.01±8.81 | 54.17 ± 7.68 | .685 |
| Gender n, (%) | |||
| Female | 50 (71.4) | 20 (28.6) | .201 |
| Male | 20 (85.0) | 3 (15.0) | |
| DM duration (years) | 10.97 ± 6.74 | 11.26 ± 6.03 | .848 |
| Smoking, n (%) | 4 (6.0) | 1 (4.3) | .909 |
| Education level, n (%) | |||
| ≤ Elementary school | 50 (74.6) | 20 (87.0) | .201 |
| ≥Elementary school | 17 (25.4) | 3 (13.0) | |
| Medication, n (%) | |||
| OAD | 26 (38.8) | 7 (30.4) | .468 |
| Insulin | 41 (61.2) | 16 (69.6) | .617 |
| Statin | 43 (64.2) | 16 (69.6) | .962 |
| MIVC, n (%) | |||
| Neuropathy | 36 (53.7) | 13 (56.5) | .816 |
| Retinopathy | 17 (25.4) | 9 (39.1) | .217 |
| Nephropathy | 3.0 (4.5) | 1.0 (4.3) | .731 |
| MAVC, n (%) | |||
| ASCVD | 19 (28.4) | 8 (34.8) | .189 |
| PAD | 1 (1.5) | 1 (4.3) | .633 |
| CVD | 1 (1.5) | 1 (4.3) | .633 |
| Comorbidities, n (%) | |||
| Hypertension | 40 (59.7) | 14 (60.9) | .921 |
| Hyperlipidemia | 46 (68.7) | 18 (78.3) | .371 |
| Obesity | 52 (77.6) | 21 (91.3) | .125 |
| Diabetes self-management, n (%) | |||
| SMBG | 39 (58.2) | 14 (60.9) | .823 |
| Diet compliance | 32 (47.8) | 11 (47.8) | .996 |
| Exercises | 23 (34.3) | 7 (30.4) | .802 |
Data are presented as n (%) and mean ± standard deviation.
T2DM = Type 2 Diabetes Mellitus; OAD = oral antidiabetics; MIVC = microvascular complications; MAVC = macrovascular complications; ASCVD = atherosclerotic cardiovascular disease; PAD = peripheral arterial disease; CVD = cerebrovascular disease; SMBG = Self Management Blood Glucose Monitoring.